• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Consumer Cyclical·AMARC.BK
Share

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited Stocks

THB 2.88Last Updated 27.07.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

THB 35.18M

THB 2.88
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Asia Medical and Agricultural Laboratory and Research Center Public Company Limited (AMARC), established in Bangkok, Thailand, in 2004, offers a broad spectrum of laboratory services, focusing primarily on the agricultural, food, and pharmaceutical sectors. This subsidiary of Ladprao General Hospital Public Company Limited provides vital support across several key areas. The company delivers extensive testing, inspection, and certification for a diverse range of products, including meat and meat products, fats, oils, pet food, feedstuffs, aquaculture items, crops, and various other food and beverage commodities. They also perform environmental analyses on water, air, and soil samples, as well as potable water and water ice. For the agricultural industry, AMARC specializes in quality control and registration for fertilizers, in addition to conducting efficacy and residue trials and providing registration assistance for hazardous substances and pesticides. In the pharmaceutical realm, their services encompass quality assurance testing, research and development for drugs and raw materials, analysis of product components, drug analysis method validation, and bioequivalence studies. They also support the cosmetics industry with quality assurance, including contaminant and challenge tests, and are involved in developing new testing methodologies for pharmaceutical products. Beyond analytical testing, AMARC offers calibration services for electrical, temperature, chemical, and mechanical metrology, alongside calibrating various medical devices such as electrocardiograms, non-invasive blood pressure devices, patient monitors, and pulse oximeters. Additionally, the company provides expert consultation and training, guiding clients through quality system preparation (including ISO/IEC 17025 standards), inspection, and certification processes, as well as optimizing laboratory tools and equipment. Further services include nutrition labeling, shelf-life assessments, and analysis of food contact materials.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of AMARC.BK is 4.30 and suggests 47.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.07.2026 17:42

"Bans Won't Help": Zuckerberg Urged the U.S. Not to Block Chinese Neural Networks

29.07.2026 17:20

Hermès shares fell to a three-year low due to weak performance in China

29.07.2026 15:27

Morning in New York: The Market Awaits a Turning Point

29.07.2026 14:40

Shares of the company in which Trump's son has invested soared 20%. It will sell part of the business

29.07.2026 14:27

SK hynix shares fell 10% following the announcement of a record quarter. What spooked the market?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026